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Abstract
The aim of this study was to evaluate the impact of the COVID-19 pandemic lockdown on acute myocardial infarction (AMI) 
care, and to identify underlying stressors in the German model region for complete AMI registration. The analysis was based 
on data from the population-based KORA Myocardial Infarction Registry located in the region of Augsburg, Germany. All 
cases of AMI (n = 210) admitted to one of four hospitals in the city of Augsburg or the county of Augsburg from February 
10th, 2020, to May 19, 2020, were included. Patients were divided into three groups, namely pre-lockdown, strict lockdown, 
and attenuated lockdown period. An additional survey was conducted asking the patients for stress and fears in the 4 weeks 
prior to their AMI. The AMI rate declined by 44% in the strict lockdown period; in the attenuated lockdown period the 
rate was 17% lower compared to the pre-lockdown period. The downward trend in AMI rates during lockdown was seen 
in STEMI and NSTEMI patients, and independent of sex and age. The door-to-device time decreased by 70–80% in the 
lockdown-periods. In the time prior to the infarction, patients felt stressed mainly due to fear of infection with Sars-CoV-2 
and less because of the restrictions and consequences of the lockdown. A strict lockdown due to the Covid-19 pandemic had 
a marked impact on AMI care even in a non-hot-spot region with relatively few cases of COVID-19. Fear of infection with 
the virus is presumably the main reason for the drop in hospitalizations due to AMI.
Keywords Covid-19 · Myocardial infarction · Lockdown · Door-to-device-time · Population-based registry · Augsburg · 
Bavaria · Germany
Introduction
Since the first reported case of Covid-19 on January 27, 
2020, in Bavaria, [1] Germany, the number of confirmed 
cases increased rapidly in early March. The exponential 
increase in newly confirmed cases reached a total of 67,366 
positively tested cases on April 1 in whole Germany [2] 
and 20,178 cases in Bavaria, the German federal state most 
affected by Covid-19. Within Bavaria, counties were affected 
to varying degrees by the pandemic; the city of Augsburg 
and the district of Augsburg were among the less affected 
counties (on April 1, 2020: 454 Covid-19-cases) [2]. On 
March 16, the Bavarian Government declared a state of 
emergency and enforced non-pharmaceutical interventions. 
These included physical distancing, hygiene, masks, isola-
tion of infected people and their contacts, and lockdowns, 
such as closures of schools and businesses and bans on pub-
lic gatherings and travel. To preserve resources, the Bavarian 
Government recommended deferral of elective procedures in 
patient care but not of care for emergency conditions such as 
acute myocardial infarction (AMI). Several recent studies, 
which were conducted in Covid-19 epicenters, reported sig-
nificant reductions of hospitalizations due to AMI during the 
onset of the Covid-19 pandemic.[3–7] So far, investigations 
of heart attack events in a region with relatively low numbers 
of Covid-19 cases but an early and strict lockdown are miss-
ing. Because the Augsburg area is one of the districts with 
fewer Covid-19 cases, we evaluated AMI care before, during 
and post the lockdown using data from the well-established, 
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population-based KORA Myocardial Infarction Registry in 
Augsburg, [8] Germany, covering all AMI events in a region 
of about 680,000 inhabitants. In addition, we examined pos-
sible stressors that prevented acute heart attack patients from 
seeking immediate inpatient treatment.
Methods
Study population
The underlying data for this analysis was collected prospec-
tively by the KORA Myocardial Infarction Registry. The 
data collection of the registry is population-based with con-
secutive enrollment of all cases of non-fatal AMI within the 
study region. The inclusion criteria are the following: the 
patient is older than 24 years, survived more than 24h in the 
hospital, and is an inhabitant of the study region of Augs-
burg (city of Augsburg and two adjacent counties Aichach-
Friedberg and Augsburg). Detailed information on case 
identification and data collection is given elsewhere. [8, 9] 
For the present study, all cases of AMI admitted from Febru-
ary 10, 2020, to May 21, 2020, were included. Patients were 
divided into three groups: pre-lockdown (February 10th to 
March 15th, 2020), strict lockdown (March 16th to April 
19th, 2020), and attenuated lockdown (April 20th to May 
21th) period. Only patients treated in the University hospi-
tal of Augsburg and 3 other hospitals located in the city of 
Augsburg and the county Augsburg were considered (about 
550,000 inhabitants). Of those, 2 hospitals (in particular 
the University hospital of Augsburg) perform cardiac cath-
eterization; the 2 hospitals without cardiac catheterization 
laboratories transfer the patients to the University hospital 
of Augsburg for invasive treatment of AMI. A total of 210 
at least 24 h surviving AMI cases were treated in one of the 
4 hospitals in this region within the study period. For the 
survey study, a questionnaire was sent out to 90 patients, of 
which 61 replied instantly or after a postal reminder (67.8%). 
Another 58 patients completed the questionnaire as a part of 
the routine interview (total response: 119). The study com-
plies with the Declaration of Helsinki. All study participants 
gave written informed consent and the study was approved 
by the Ethics Committee of the Bavarian Medical Associa-
tion (Bayerische Landesärztekammer).
Data collection
The study participants were interviewed shortly after inten-
sive care by study nurses and further data were collected by 
review of the medical chart and discharge report. Informa-
tion on the acute event (time of symptom onset), treatment 
procedures (PCI, coronary artery bypass grafting) compli-
cations during hospital stay (cardiogenic shock, ventricular 
fibrillation, in-hospital mortality), cardiopulmonary resus-
citation in- or outside the hospital, type of AMI (STEMI/
NSTEMI), time from symptom onset to hospital admission, 
time from admission to revascularization, and information 
on physician diagnosis of diabetes were gathered.
In addition to the routinely collected data, an observa-
tional, cross-sectional study on perceived stress was per-
formed. A questionnaire was created, which contained two 
single items on a past or current infection with SARS-CoV-2 
among the respondents and infections in their social envi-
ronment. Further, the intensity of perceived stress with 
regards to 19 different situations, events or feelings in the 
last 4 weeks before the MI was requested. The question 
was: “In the 4 weeks before your heart attack, how much 
did you feel stressed by the following situations, events or 
feelings?”. The response options were: 1 = not at all/does 
not apply, 2 = slightly, 3 = moderately, 4 = severely, 5 = very 
severely. For this survey, only patients who were included in 
the routine data collection of the registry were considered. 
For patients with AMI between early March and mid-May 
the questionnaires were sent out on May, 18th and in case 
of non-responding, a postal reminder was sent out on June, 
10th. Patients with AMI between mid-May and end of June 
received the questionnaire in the context of the interview 
that was conducted routinely as part of the data collection 
of the registry. AMI patients who died during their hospital 
stay were not considered for the survey.
Figure 1 provides a Flow Chart, which illustrates the pro-
cess of data collection for the hospitalized AMI´s and the 
additional survey.
Statistical analysis
Summary statistics were provided for the pre-lockdown 
period and two the lockdown periods. We calculated AMI 
rates with exact Poisson 95% confidence intervals (CI). 
Cumulative person time (in years) since the beginning of 
the study period (i.e., February 10th, March 16th, and April 
20th) was computed. Age- and sex-adjusted rate ratios (RR) 
and time ratios (TR) for the comparison of the two lockdown 
periods and the pre-lockdown period were estimates using 
negative binomial regression models.
For the multi-item questionnaire on perceived stress, a 
factor analysis was conducted to clarify whether a summary 
score can be calculated. Adequacy of the data for factor 
analysis was assessed by performing Bartlett-Test for sig-
nificant correlation of the items and calculating values of 
the Kaiser–Meyer–Olkin-Test (KMO). The appropriate num-
ber of factors was determined according Valicer’s minimum 
average partial test and parallel analysis. Finally, principal 
component analysis with varimax rotation was performed. 
Differences between the factors were analyzed by perform-
ing analysis of variance (ANOVA) and post-hoc-t-tests with 
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Bonferroni adjustment. P-values < 0.05 were considered sta-
tistically significant. All analyses were performed using R 
(version 3.6.3).
Results
A total of 210 patients with AMI were included in the analy-
sis of infarction rates before and during the first lockdown 
in Germany. Table 1 depicts patient characteristics accord-
ing to one pre-lockdown period and two lockdown periods. 
About 70% of the study population were men. The mean 
age was 68.1 (standard deviation [SD]: 11.9) in men and 
73.9 (SD: 13.5) in women. Overall, 42.4% were diagnosed 
with a STEMI, 55.7% had an NSTEMI, 31.0% had a diag-
nosis of type 2 diabetes, 78.6% had their first AMI, 6.2% 
died during the hospital stay, and 10.5% showed in-hospital 
complications.
The AMI rate declined by 44% (95% CI: 53%-34%) in the 
first period after lockdown compared to the pre-lockdown 
phase (Table 2). During the second post-lockdown period, 
the rate was 17% lower compared to the pre-lockdown 
period (RR = 0.83, 95% CI 0.70–0.96). The downward trend 
in myocardial infarction rates during lockdown was similar 
in men and women, and STEMI and NSTEMI patients. In 
comparison to the pre-lockdown period, the decline in myo-
cardial infarction rates in the strict lockdown period was 
most pronounced in patients aged 55 or less (RR = 0.29, 95% 
CI 0.15–0.42), those aged 66–74 years (RR = 0.26, 95% CI 
0.16–0.37), and individuals aged 75 or more (RR = 0.28, 
95% CI 0.21–0.35). In the age group 55–65 years there was 
a decline in infarction rates (RR = 0.41, 95% CI 0.29–0.54) 
as well, yet less pronounced than in other age groups. During 
the attenuated lockdown phase, rates tended to move back to 
pre-lockdown levels.
Overall, the time ratio of symptom-to-door time increased 
from 1.0 (reference) in the pre-lockdown phase to 4.25 
(95% CI 2.13–8.82) in the strict lockdown phase (which is 
equivalent to an increase of 325% (95% CI 113%-782%)). 
Thereafter, time ratio of symptom-to-door time decreased to 
0.18 (95% CI 0.09–0.33) for the attenuated lockdown phase. 
Fig. 1  A flow chart displaying the study population and the process of data collection for the rates of hospitalized AMI´s and for the survey
Table 1  Patient characteristics (n (%)) before and during two lock-
down periods due to the Covid-19 pandemic
STEMI: ST-segment elevation myocardial infarction. NSTEMI: non-
ST-segment elevation myocardial infarction. Complication includes 
out-of-hospital or in-hospital resuscitation, in-hospital cardiogenic 
shock, and in-hospital ventricular fibrillation
Pre-lockdown 




phase (n = 53)





Apr 20–May 21 
2020
Men 67 (72.8) 40 (75.5) 39 (60.0)
Age
 < 55 years 13 (14.6) 5 ( 9.6) 6 ( 9.8)
55–65 years 24 (27.0) 16 (30.8) 15 (24.6)
66–74 year 12 (13.5) 13 (25.0) 13 (21.3)
75 + years 40 (44.9) 18 (34.6) 27 (44.3)
STEMI 39 (42.4) 24 (45.3) 26 (40.0)
NSTEMI 51 (55.4) 29 (54.7) 37 (56.9)
Diabetes 31 (33.7) 14 (26.4) 20 (30.8)
First infarction 76 (82.6) 38 (71.7) 51 (78.5)
In-hospital 
mortality
6 ( 6.5) 1 ( 1.9) 6 ( 9.2)
Complication 9 ( 9.8) 3 ( 5.7) 10 (15.4)
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Table 2  Rate ratios and time 
ratios for hospital admission of 
patients with acute myocardial 
infarction, symptom-to-door 
and door-to-device time before 
and during the two lockdown 
periods due to the Covid-19 
pandemic
Rate per cumulative person time (in years). CI denotes confidence interval, STEMI: ST-segment elevation 
myocardial infarction and NSTEMI: non-ST-segment elevation myocardial infarction
Pre-lockdown Strict lockdown Attenuated lockdown
Feb10- Mar 15 Mar 16- Apr 19 Apr 20- May 19
Total sample
Rate (95% CI) 0.94 (0.02; 5.44) 0.53 (0.01; 2.96) 0.78 (0.02; 4.33)
Rate ratio (95% CI) 1.0 0.56 (0.47; 0.66) 0.83 (0.70; 0.96)
Men
Rate (95% CI) 1.72 (0.04; 9.6) 0.92 (0.02; 5.11) 0.98 (0.02; 5.47)
Rate ratio (95% CI) 1.0 0.53 (0.36; 0.70) 0.57 (0.41; 0.73)
Women
Rate (95% CI) 0.68 (0.02; 3.79) 0.31 (0.01; 1.71) 0.46 (0.01; 1.71)
Rate ratio (95% CI) 1.0 0.46 (0.37; 0.54) 0.68 (0.55; 0.81)
Age: < 55 years
Rate (95% CI) 0.94 (0.02; 5.26) 0.27 (0.01; 1.52) 0.49 (0.01; 2.73)
Rate ratio (95% CI) 1.0 0.29 (0.15; 0.42) 0.52 (0.29; 0.76)
Age: 55–65 years
Rate (95% CI) 1.21 (0.03; 6.67 0.50 (0.01; 2.77) 1.03 (0.03; 5.75)
Rate ratio (95% CI) 1.0 0.41 (0.29; 0.54) 0.85 (0.58; 1.12)
Age: 66–74 years
Rate (95% CI) 2.09 (0.05; 11.63) 0.55 (0.01; 3.07) 1.57 (0.04; 8.77)
Rate ratio (95% CI) 1.0 0.26 (0.16; 0.37) 0.75 (0.46; 1.05)
Age: 75 + years
Rate (95% CI) 4.62 (0.12; 25.76) 1.29 (0.03; 7.17) 1.48 (0.04; 8.24)
Rate ratio (95% CI) 1.0 0.28 (0.21; 0.35) 0.32 (0.24; 0.40)
STEMI
Rate (95% CI) 0.84 (0.01; 5.24) 0.42 (0.01; 2.36) 0.68 (0.02; 3.78)
Rate ratio (95% CI) 1.0 0.50 (0.38; 0.62) 0.81 (0.61; 1.01)
NSTEMI
Rate (95% CI) 0.36 (0.01, 2.02) 0.23 (0.01; 1.28) 0.40 (0.01; 2.24)
Rate ratio (95% CI) 1.0 0.64 (0.50; 0.78) 1.11 (0.88; 1.34)
Symptom-to-door time
Total sample
Hours (mean, sd) 21.2 (49.5) 67.1 (355.8) 3.3 (3.7)
Time ratio (95% CI) 1.0 4.25 (2.13; 8.82) 0.18 (0.09; 0.33)
STEMI
Hours (mean, sd) 10.5 (24.9) 3.3 (4.3) 2.9 (3.0)
Time ratio (95% CI) 1.0 0.31 (0.15; 0.69) 0.30 (0.15; 0.63)
NSTEMI
Hours (mean, sd) 31.1 (62.9) 138.9 (517.7) 3.7 (4.2)
Time ratio (95% CI) 1.0 6.68 (2.51; 19.50) 0.13 (0.06; 0.31)
Door-to-device time
Total sample
Hours (mean, sd) 30.2 (104.4) 5.2 (6.2) 7.0 (9.2)
Time ratio (95% CI) 1.0 0.23 (0.13; 0.42) 0.26 (0.15; 0.44))
STEMI
Hours (mean, sd) 3.6 (6.5) 1.0 (0.6) 1.4 (1.5)
Time ratio (95% CI) 1.0 0.26 (0.14; 0.49) 0.35 (0.19; 0.63)
NSTEMI
Hours (mean, sd) 52.3 (146.6) 10.9 (5.7) 12.1 (10.2)
Time ratio (95% CI) 1.0 0.19 (0.09; 0.40) 0.20 (0.11; 0.37)
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However, there were notable differences between cases diag-
nosed with STEMIs and NSTEMIs. The symptom-to-door 
times shortened in STEMI (TR = 0.31, 95% CI 0.15–0.69) 
and increased in NSTEMI (TR = 6.68, 95% CI 2.51–19.50) 
cases. The door-to-device time decreased 70–80% during 
lockdown-periods compared to the pre-lockdown phase, 
overall, and in the STEMI and NSTEMI cases.
Survey
A total of 119 patients completed the questionnaire. Of 
those, 61 answered to the postal questionnaire (out of 90 
who received the questionnaire, response rate: 67.8%). 
Another 58 questionnaires were carried out in the hos-
pital as part of the routinely conducted interview. Mean 
age of the patients included in the survey was 70.3 years 
(SD: 11.7); 79 of those were men (66.4%). A total of 113 
(95.0%) patients had no infection with Sars-CoV-2 until 
the time of the interview. One patient (0.8%) indicated 
a current infection and one patient (0.8%) had already 
recovered from Covid-19. Another 4 patients (3.4%) stated 
they don´t know whether they had an infection with Sars-
CoV-2. Most patients (n = 99, 83.2%) had no affected per-
sons in their social environment. There were no confirmed 
current infections among the patients’ social environment, 
but 3 patients (2.5%) claimed that there are unconfirmed 
suspected cases. Additionally, 5 patients (4.2%) stated that 
there are recovered persons, and 3 patients (2.5%) had per-
sons in their social environment, who died from Covid-19.
The main question on perceived stress (19 items) aimed 
at situations, occasions, and feeling, by which patients 
felt stressed or burdened during the 4 weeks before AMI. 
Detailed results are displayed in Table 3. The factor analy-
sis revealed an optimum of 4 factors (see Tables 3, 4), 
which are the following: Factor 1: job/finances (5 items). 
Factor 2: family/friends/social environment (7 items). 
Factor 3: infection with coronavirus (3 items). Factor 
4: society/social life (3 items). Based on these results, 
corresponding subscale scores were built by adding the 
responses of the single items.
Analysis of variance revealed significant differences 
between the factors. Post-hoc t-tests using Bonferroni 
adjustment were performed to further analyze the differ-
ences (see Table 4 and Fig. 2). It was found, that stress due 
to fear of infection with Sars-CoV-2 (factor 3) was signifi-
cantly more frequent among the patients than stress due to 
the three other categories. Stress caused by the restrictions 
in social life/society (factor 4: loneliness/isolation, lim-
ited social contact and leisure activities) was significantly 
higher than stress generated by job/finances (factor 1) and 
family/friends/social environment (factor 2).
Table 3  Perception of stress in patients with acute myocardial infarction: Answers to the question: “In the 4 weeks before your heart attack, how 
much did you feel stressed by the following situations, events or feelings?” are displayed as total number (percentages) and mean (SD)
Factor n Not at all/does not apply Slightly Moderately Severely Very severely Mean (SD)
Conflicts with related persons 2 117 84 (71.8%) 18 (15.4%) 8 (6.8%) 5 (4.3%) 2 (1.7%) 1.49 (0.92)
Dependents in need of care 2 116 100 (86.2%) 8 (6.9%) 4 (3.4%) 1 (0.9%) 3 (2.6%) 1.27 (0.80)
Constant accessibility 2 117 81 (69.2%) 17 (14.5%) 8 (6.8%) 6 (5.1%) 5 (4.3%) 1.61 (1.10)
Many private obligations 2 116 81 (69.8%) 20 (17.2%) 5 (4.3%) 7 (6.0%) 3 (2.6%) 1.54 (1.01)
Death of related person 2 116 105 (89.7%) 5 (4.3%) 2 (1.7%) 2 (1.7%) 3 (2.6%) 1.23 (0.79)
Worries about health of a related 
person
2 118 61 (51.7%) 26 (22.0%) 14 (11.9%) 10 (8.5%) 7 (5.9%) 1.95 (1.23)
Separation from partner 2 118 109 (92.4%) 3 (2.5%) 0 (0.0%) 2 (1.7%) 4 (3.4%) 1.21 (0.83)
Current financial situation 1 117 88 (75.2%) 17 (14.5%) 7 (6.0%) 3 (2.6%) 2 (1.7%) 1.41 (0.85)
Financial future 1 117 81 (69.2%) 24 (20.5%) 8 (6.8%) 2 (1.7%) 2 (1.7%) 1.46 (0.84)
Current job-related situation 1 116 89 (76.7%) 8 (6.9%) 9 (7.8%) 5 (4.3%) 5 (4.3%) 1.53 (1.09)
Future job-related situation 1 116 93 (80.2%) 8 (6.9%) 7 (6.0%) 2 (1.7%) 6 (5.2%) 1.45 (1.05)
Loneliness/isolation 4 118 85 (72.0%) 18 (15.3%) 10 (8.5%) 3 (2.5%) 2 (1.7%) 1.47 (0.88)
Limited leisure activities 4 117 65 (55.6%) 17 (14.5%) 16 (13.7%) 14 (12.0%) 5 (4.3%) 1.95 (1.25)
Family situation 2 117 80 (68.4%) 20 (17.1%) 7 (6.0%) 9 (7.7%) 1 (0.9%) 1.56 (0.97)
Feeling of excessive demands 1 117 82 (70.1%) 15 (12.8%) 8 (6.8%) 8 (6.8%) 4 (3.4%) 1.61 (1.1)
Less contact with other people 4 118 68 (57.6%) 22 (18.6%) 15 (12.7%) 10 (8.5%) 3 (2.5%) 1.85 (1.11)
Health situation in Germany 3 113 54 (47.8%) 38 (24.8%) 16 (14.2%) 12 (10.6%) 3 (2.7%) 1.96 (1.14)
Fear of infection with new Corona-
virus
3 118 51 (43.2%) 43 (36.4%) 13 (11.0%) 5 (4.2%) 6 (5.1%) 1.92 (1.08)
Fear of infection of a related person 
with new Corona-virus
3 117 40 (34.2%) 42 (35.9%) 17 (14.5%) 12 (10.3%) 6 (5.1%) 2.16 (1.16)
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Discussion
We observed a reduction in AMI cases by almost 50% 
in the five weeks of strict lockdown in our non-hot-spot 
Covid-19 study region. A reduction was seen in STEMIs 
as well as NSTEMI cases, the latter with an even greater 
drop in numbers. Men and women and age groups were 
similarly affected by the downturn. In addition, our study 
showed a reduction in door-to-device time for both patients 
with STEMI and NSTEMI. In contrast, the symptom-to-
door-time decreased in STEMI patients but increased 
markedly in NSTEMI patients during the strict lockdown. 
During the attenuated lockdown phase, a trend towards the 
conditions of the pre-lockdown period is seen. It seems 
that the predominant reason for the drop of cases was 
stress by fear of infection with the virus.
Although our study area was not located in an epicenter 
of the pandemic in spring 2020, there has been a massive 
decrease in AMI cases during the lockdown period, a find-
ing almost similar to reports from Austria, [7] Italy, [4, 
5] North America, [3, 6, 10–12] and Spain, [13] in which 
mostly data from pandemic epicenters were analyzed. In 
this study, the door-to-device time for both STEMI and 
NSTEMI patients diminished during the lockdown. On 
the other hand, there was an increase in symptom-to-door 
time among NSTEMI patients. An early study from Hong 
Kong, [14] China, suggested a large delay in the time from 
symptom onset to first medical contact after the onset of 
the pandemic. Contrary to our findings, an investigation 
from another non-hot-spot region in the US reported a 
delay in presentation and a longer average door-to-device 
time in STEMI patients. The authors suggested that these 
delays were due to fear of Covid-19, or in belief of patients 
that the symptoms were Covid-19 related, or that patients 
did not want to burden the emergency department during 
the Covid-19 pandemic. [11] The pre-hospital phase of 
ischemic duration, particularly in STEMI, is strongly asso-
ciated with patient outcomes, [15, 16] and the in-hospital 
timing of treatment is critically important. [17, 18] Short 
door-to-device-times are key components of efficient rep-
erfusion therapy in AMI care [19].
Table 4  A factor analysis was 
conducted to characterize 
perception of stress in patients 
with acute myocardial infarction
The factor analysis revealed an optimum of 4 factors, which are the following: Factor 1: job/finances; Fac-
tor 2: family/friends/social environment; Factor 3: fear of infection with Sars-Cov-2; Factor 4: society/
social life. An analysis of variance (ANOVA) revealed significant differences among the factors. Post-hoc 
t-tests were performed to further analyze differences between each of the 4 factors. Factor 3 had significant 
higher values than the remaining factors. Factor 4 was rated significantly higher than factor 2 and 1. The 
two latter ones did no vary significantly from each other
Actor analysis ANOVA 
p-value: < 0.0001
Post-hoc-t-test (Bonferroni adjustment) 
p-values
mean (SD) Factor 2 Factor 3 Factor 4
Factor 1:
Job/finances
1.49 (0.99) 1  < 0.0001 0.00253
Factor 2:
Family/friends/social environment
1.48 (0.99) –  < 0.0001 0.00049
Factor 3:
Fear of infection with Sars-Cov-2
2.01 (1.13) – – 0.00260
Factor 4:
Society/social life
1.74 (1.11) – – –
Fig. 2  The main question of the survey was: “In the 4 weeks before 
your heart attack, how much did you feel stressed by the following 
situations, events or feelings?” (see Table 3 for the all items of this 
question). Figure 2 displays the percentages of given answers for each 
of the 4 factors that were identified by factor analysis (see Table 4): 
Factor 1: stress by job/finances, Factor 2: stress due to family/
friends/social environment, Factor 3: stress caused by fear of infec-
tion with Sars-Cov-2, Factor 4: stressed by society/social life. Figure 
generated with R version 3.6.3
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In contrast to the present findings, one could have 
expected a rise in AMI cases due to various reasons. Psy-
chosocial and environmental stress caused by the pandemic 
might have led to an increased incidence of AMI. Moreo-
ver, higher numbers of infarction cases could be induced 
by respiratory infections and viral illness due to 2019 novel 
Coronavirus (SARS-CoV-2), which can also be observed for 
influenza infections [20].
There are several possible explanations for the drop in 
cases. One major hypothesis is, that the reduction in hos-
pitalizations due to AMI is caused by an actual reduction 
in cases, which could be a result of reduced physical stress 
and working stress during quarantine and lockdown times. 
However, the decrease in cases can be observed in all age 
groups including patients aged 70 years or older. Since most 
people in this age group are retired, the argument of reduc-
tion of physical stress or working stress is probably not valid. 
Moreover, meta-analyses concluded, that the pandemic has 
also caused additional psychological stress, fears and anxi-
ety as well as a number of newly diagnosed mental disorders 
[21, 22]. Consequently, it appears implausible, that reduced 
levels of stress as a consequence of the lockdown measures 
led to lower numbers of AMI in March and April.
The second main hypothesis is a reduced willingness to 
seek medical help by the patients. The main reason for this 
might be fear of in-hospital infection with SARS-CoV-2 
and a lower perceived necessity to seek help. This effect 
probably applies primarily to milder events. The results of 
our patient survey via questionnaire revealed, that in the 
4 weeks prior to the event, patients were mainly stressed 
by fear of infection with the virus (infection of themselves 
and even more by fear of infections of close relatives) and 
by the health situation in Germany itself. This strengthens 
the hypothesis that patients with typical AMI symptoms 
hesitated to seek medical help due to fear of infection in 
the hospital. We assume this to be the predominant reason 
for the drop of cases in the early weeks of the lockdown. 
Ciofani et al. reported, that the internet search volume for 
chest pain strongly correlated with Covid-19 case numbers 
in the USA [23]. They suspected, that fear of Covid-19 may 
lead patients to self-triage using internet research and in this 
way avoid hospital visits, which would be in agreement with 
our results.
Our survey further revealed, that situations and events 
other than fear of Covid-19 generated less stress. Restric-
tions in social life (reduced contact to others, loneliness/
isolation, limited possibilities of free time activities) caused 
a medium amount of stress in the 4 weeks prior to the event. 
These restrictions are mostly caused by lockdown and con-
tainment measures. Nevertheless, they generated less stress 
and worries than the virus itself.
The least amount of stress was caused by affaires con-
cerning family, friends or close social environment (e.g. 
conflicts, private obligations or separation from partner) 
and financial and job-related worries. The latter might be 
explained on the one hand by the presumabley large number 
of patients who are already retired and not dependent on jobs 
for their financial incomes. On the other hand, this survey 
was conducted in an early phase of the pandemics (March to 
June) and economic consequences like job losses and insol-
vencies of companies emerged mainly in the further course 
of the year 2020.
Overall, fear of infection and the health situation in Ger-
many was by far the most important source of stress. Fur-
thermore, patients felt stressed more through restrictions of 
social life and less through financial or job-related worries 
and affairs of close social environment. It has to be consid-
ered, that persons experiencing a heart attack do not repre-
sent the general population as they are older and have more 
comorbidities and are predominately men. So, these results 
are specifically valid for patients with a high risk of AMI 
and not for other groups of patients. Additionally, it has to 
be mentioned, that the patients who presumably had a MI 
but did not seek medical help are missing in this survey. It 
remains unclear, if their fears and worries differ from those 
of the patients who participated in this survey.
As a consequence of the fear of Covid-19 disease and the 
hesitation to seek medical help, it wouldn´t be surprising 
to see an increase in prehospital time. This is what other 
researchers have found after onset of the corona pandemics 
in other countries [11, 14]. Nevertheless, we observed this 
in our data for NSTEMI patients only. In fact, there was a 
drop in prehospital time for STEMI patients and a decrease 
in door-to-device time in both STEMI and NSTEMI patients 
compared to the time-period before the lockdown. This 
reduction in symptom-to-door time for STEMI and door-to-
device-time might, in part, be explained by a higher propor-
tion of more severe cases, which are usually characterized 
by more pronounced symptoms.
Another fact that needs to be considered when interpret-
ing the data is that the Covid-19 pandemic could be attenu-
ated at an early phase in spring 2020 in Germany, except for 
a few cluster events (e.g. the district of Heinsberg), and the 
health care system was never overwhelmed during the out-
break. This also applies to the hospitals in the study region. 
As in non-Covid-19 times, the PCI resources were kept 
running during the pandemic. Thus, a short door-to-device 
time for the STEMIs and NSTEMIs could be maintained 
throughout, and even improved overall. A likely explanation 
is that the treatment of elective cases was eliminated during 
the lockdown, and therefore sufficient treatment capacities 
were available at all times for AMI patients. This difference 
in comparison to other, harder-hit countries might be the 
main explanation for the reduction in door-to-device time.
Untreated AMI can cause severe complications and 
substantial vascular damage, including heart failure, [24] 
626 T. Schmitz et al.
1 3
ventricular arrhythmias, [25] ventricular remodeling [26] 
and premature death. As our data can be considered repre-
sentative due to the population-based structure of this reg-
istry, a transfer of our findings to the whole country results 
in a considerable reduction of medically treated AMI cases 
for the calendar weeks 12 to 16. Assuming most of missing 
cases still occurred during this time but simply without 
adequate treatment, this would mean substantial collat-
eral damage. Fortunately, the quality of medical care for 
patients with AMI seeking for help remained on the same 
high level during the lockdown as it was before the pan-
demic. In this regard, it seems to be important to encour-
age people to seek help when they experience chest pain 
in times of a pandemic.
The present study has some limitations and strengths. 
Data collection during a pandemic is challenging because 
it is necessary to provide human resources for the care 
of Covid-19 patients. Thus, extensive data collection 
by a detailed chart review was not possible. Therefore, 
some relevant information such as behavioral risk factors, 
comorbidities, and laboratory parameters were unavailable 
for the present study.
Further to mention is a relatively small sample size of 
53 recorded cases of hospitalized myocardial infarction 
during the strict lockdown phase and a total of 119 patients 
that completed the questionnaire. Patients that participated 
in the survey were recruited in two different ways: patients 
with AMI in the early phase of the lockdown received a 
postal invitation and patients with AMI in the attenuated 
lockdown phase completed the questionnaire during their 
hospital stay as part of the common data collection of this 
registry. This circumstance might have led to a selection, 
recall or interviewer bias.
Nonetheless, the questionnaire on perceived stress of 
the patients in the time 4 week prior to the events gives 
additional insights and draws a larger picture of the situa-
tion. The questionnaire was self-developed and specifically 
designed for the pandemic situation in order to address the 
uniqueness of the situation as best as possible. An evalua-
tion of its psychometric properties was not possible prior 
to the use in the current study, which must be considered 
as weakness.
A major strength of this study is the use of the pop-
ulation-based registry and its consecutive enrollment of 
patients within a defined study region including urban 
and rural areas. This excludes relevant selection bias 
and ensures that results from this registry are fairly rep-
resentative for the German population. Since the KORA 
Myocardial Infarction Registry prospectively collects all 
cases of AMI in the study region of Augsburg, subsequent 
investigations on the effects of the lockdown phase on fatal 
(including pre-hospital deaths) and non-fatal events and 
on the occurrence of re-infarctions and complications can 
further contribute to the understanding of those issues.
Acknowledgements Steering partners of the KORA Myocardial 
Infarction Registry, Augsburg, include the KORA research platform, 
Helmholtz Zentrum München and the Department of Internal Medicine 
I, Cardiology, University Hospital of Augsburg. We thank the Myocar-
dial Infarction Register teams in Augsburg and Munich for data col-
lection and management, in particular Hildegard Golüke and Dorothea 
Lukitsch. Furthermore, we thank the clinicians of the hospitals within 
the study area for their support. Finally, we express our appreciation 
to all study participants.
Author contributions All authors of the manuscript meet the ICMJE 
Authorship Criteria. They substantially contributed to conception and 
design, acquisition of data, drafting of the article, critical revision, and 
final approval of the manuscript.
Funding Open Access funding enabled and organized by Projekt 
DEAL. The KORA research platform and the MONICA Augs-
burg studies were initiated and financed by the Helmholtz Zentrum 
München, German Research Center for Environmental Health, which 
is funded by the German Federal Ministry of Education, Science, 
Research and Technology and by the State of Bavaria. Since the year 
2000, the collection of AMI data has been co-financed by the German 
Federal Ministry of Health to provide population-based AMI morbidity 
data for the official German Health Report (see www. gbe- bund. de).
Availability of data and material The data underlying this article cannot 
be shared publicly because the data are subject to national data protec-
tion laws and restrictions that were imposed by the ethics committee of 
the Bavarian Medical Association ("Bayerische Landesärztekammer") 
to ensure data privacy of the study participants because they did not 
explicitly consent to the data being madepublicly available. The data 
will be shared on reasonable request to the corresponding author.
Code availability Available on reasonable request to the correspond-
ing author.
Declarations 
Conflict of interest The authors have no conflicts of interest to declare 
that are relevant to the content of this article.
Ethical approval The study complies with the Declaration of Helsinki. 
The study was approved by the Ethics Committee of the Bavarian Med-
ical Association (Bayerische Landesärztekammer).
Consent to participate Written informed consent was obtained from 
the parents.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
627Impact of COVID-19 pandemic lockdown on myocardial infarction care 
1 3
References
 1. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wall-
rauch C, et al. Transmission of 2019-nCoV infection from an 
asymptomatic contact in Germany. N Engl J Med. 2020;382:970–
1. https:// doi. org/ 10. 1056/ NEJMc 20014 68.
 2. Robert Koch-Institut. COVOD-19-Dashboard. https:// exper ience. 
arcgis. com/ exper ience/ 47822 0a4c4 54480 e823b 17327 b2bf1 d4.
 3. Abdelaziz HK, Patel B, Chalil S, Choudhury T. COVID-19 Pan-
demic and acute myocardial infarction: management protocol 
From a British cardiac centre. Crit Pathw Cardiol. 2020;19:55–7. 
https:// doi. org/ 10. 1097/ HPC. 00000 00000 000222.
 4. de Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto 
F, Saglietto A, et al. Reduced rate of hospital admissions for 
ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 
2020;383:88–9. https:// doi. org/ 10. 1056/ NEJMc 20091 66.
 5. de Rosa S, Spaccarotella C, Basso C, Calabrò MP, Curcio 
A, Filardi PP, et  al. Reduction of hospitalizations for myo-
cardial infarction in Italy in the COVID-19 era. Eur Heart J. 
2020;41:2083–8. https:// doi. org/ 10. 1093/ eurhe artj/ ehaa4 09.
 6. Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich 
R, Jaffer FA, et al. Reduction in ST-segment elevation cardiac 
catheterization laboratory activations in the United States during 
COVID-19 pandemic. J Am Coll Cardiol. 2020. https:// doi. org/ 
10. 1016/j. jacc. 2020. 04. 011.
 7. Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. 
Decline of acute coronary syndrome admissions in Austria since 
the outbreak of COVID-19: the pandemic response causes cardiac 
collateral damage. Eur Heart J. 2020;41:1852–3. https:// doi. org/ 
10. 1093/ eurhe artj/ ehaa3 14.
 8. Löwel H, Lewis M, Hörmann A, Keil U. Case finding, data qual-
ity aspects and comparability of myocardial infarction regis-
ters: results of a south German register study. J Clin Epidemiol. 
1991;4356(91):90036–9. https:// doi. org/ 10. 1016/ 0895- 4356(91) 
90036-9.
 9. Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, 
Meisinger C. 20-year trends in clinical characteristics, therapy 
and short-term prognosis in acute myocardial infarction accord-
ing to presenting electrocardiogram: the MONICA/KORA AMI 
Registry (1985–2004). J Intern Med. 2008;264:254–64. https:// 
doi. org/ 10. 1111/j. 1365- 2796. 2008. 01956.x.
 10. Kazi DS, Wadhera RK, Shen C, Ho KKL, Patell R, Selim MH, 
et al. Decline in Emergent and Urgent Care during the COVID-19 
Pandemic: Cold Spring Harbor Laboratory; 2020. https:// doi. org/ 
10. 1101/ 2020. 05. 14. 20096 602.
 11. Hammad TA, Parikh M, Tashtish N, Lowry CM, Gorbey D, 
Forouzandeh F, et al. Impact of COVID-19 pandemic on ST-eleva-
tion myocardial infarction in a non-COVID-19 epicenter. Catheter 
Cardiovasc Interv Off J Soc Cardiac Angiogr Interv. 2020. https:// 
doi. org/ 10. 1002/ ccd. 28997.
 12. Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, 
Adjemian J, Gundlapalli AV. Impact of the COVID-19 pandemic 
on emergency department visits—United States, January 1, 2019-
May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:699–
704. https:// doi. org/ 10. 15585/ mmwr. mm692 3e1.
 13. Rodriguez-Leor O, Cid-Alvarez B. ST-segment elevation myocar-
dial infarction care during COVID-19: losing sight of the forest 
for the trees. JACC Case rep. 2020;2:1625–7. https:// doi. org/ 10. 
1016/j. jaccas. 2020. 04. 011.
 14. Tam C-CF, Cheung K-S, Lam S, Wong A, Yung A, Sze M, Impact 
of Coronavirus Disease, , et al. (COVID-19) Outbreak on ST-seg-
ment-elevation myocardial infarction care in Hong Kong. China 
Circ Cardiovasc Qual Outcomes. 2019;2020(13):e006631. https:// 
doi. org/ 10. 1161/ CIRCO UTCOM ES. 120. 006631.
 15. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, 
French WJ, et  al. Relationship of symptom-onset-to-balloon 
time and door-to-balloon time with mortality in patients under-
going angioplasty for acute myocardial infarction. JAMA. 
2000;283:2941–7. https:// doi. org/ 10. 1001/ jama. 283. 22. 2941.
 16. Denktas AE, Anderson HV, McCarthy J, Smalling RW. Total 
ischemic time: the correct focus of attention for optimal ST-
segment elevation myocardial infarction care. JACC Cardiovasc 
Interv. 2011. https:// doi. org/ 10. 1016/j. jcin. 2011. 02. 012.
 17. Ryota N. Shorter door to balloon time, better long term clinical 
outcomes in st-segment elevation myocardial infarction patients 
Japanese registry of acute myocardial infarction diagnosed by uni-
versal definition substudy. J Am Coll Cardiol. 2020;75:14. https:// 
doi. org/ 10. 1016/ S0735- 1097(20) 30641-0.
 18. Tan LL, Zheng H, Chow KY, Loh J, Chua T, Tan HC, Foo D, 
Ong HY, Tong KL, Richards M, Chan M. Door-to-balloon time 
correlates better with patients outcomes than symptom-to-balloon 
time. J American Coll Cardiol. 2016;67(13):469. https:// doi. org/ 
10. 1016/ S0735- 1097(16) 30470-3.
 19. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, 
de Lemos JA, et al. 2013 ACCF/AHA guideline for the manage-
ment of ST-elevation myocardial infarction: executive summary: 
a report of the American college of cardiology foundation/Ameri-
can heart association task force on practice guidelines. Circula-
tion. 2013;127:529–55. https:// doi. org/ 10. 1161/ CIR. 0b013 e3182 
742c84.
 20. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crow-
croft NS, Karnauchow T, et  al. Acute Myocardial Infarction 
after laboratory-confirmed influenza infection. N Engl J Med. 
2018;378:345–53. https:// doi. org/ 10. 1056/ NEJMo a1702 090.
 21. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor 
S, Mohammadi M, et al. Prevalence of stress, anxiety, depression 
among the general population during the COVID-19 pandemic: a 
systematic review and meta-analysis. Global Health. 2020. https:// 
doi. org/ 10. 1186/ s12992- 020- 00589-w.
 22. Kontoangelos K, Economou M, Papageorgiou C. Mental Health 
effects of COVID-19 pandemia: a review of clinical and psycho-
logical traits. Psychiatry Investig. 2020;17:491–505. https:// doi. 
org/ 10. 30773/ pi. 2020. 0161.
 23. Ciofani JL, Han D, Allahwala UK, Asrress KN, Bhindi R. Internet 
search volume for chest pain during the COVID-19 pandemic. Am 
Heart J. 2020. https:// doi. org/ 10. 1016/j. ahj. 2020. 09. 005.
 24. Cleland JGF, Torabi A, Khan NK. Epidemiology and manage-
ment of heart failure and left ventricular systolic dysfunction in 
the aftermath of a myocardial infarction. Heart. 2005;91 Suppl 
2:ii7–13; discussion ii31, ii43–8. doi:https:// doi. org/ 10. 1136/ hrt. 
2005. 062026
 25. St John Sutton M, Lee D, Rouleau JL, Goldman S, Plappert T, 
Braunwald E, Pfeffer MA. Left ventricular remodeling and ven-
tricular arrhythmias after myocardial infarction. Circulation. 
2003;107:2577–82. https:// doi. org/ 10. 1161/ 01. CIR. 00000 70420. 
51787. A8.
 26. Pfeffer MA, Braunwald E. Ventricular remodeling after myo-
cardial infarction. Expe obs clin implic Circ. 1990;81:1161–72. 
https:// doi. org/ 10. 1161/ 01. cir. 81.4. 1161.
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
